Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 9: Vascular Diseases & Diabetic Retinopathy II

14:30 - 16:00 | 21 September | Room: Room D1.

Back to Previous

14:30Reallife anatomical and visual acuity outcomes in treatmentnaive patients treated with intravitreal aflibercept for diabetic macular oedema; 18 months results
M. Lukic United Kingdom
14:36EVAPOR: Evaluation of Argon versus Pascal® laser efficacy on diabetic macular edema resorption
m. Saleh France
14:42Predictors of early diabetic retinopathy improvement in patients with diabetic macular edema who received 3 or more monthly ranibizumab injections
P. Schlottmann Argentina
14:48AntiVEGF/Anti–angiopoietin2 bispecific antibody RG7716 in diabetic macular edema: Key efficacy and safety results from the phase 2 BOULEVARD clinical trial
R. Tadayoni France
14:54AntiVEGF/Anti–angiopoietin2 bispecific antibody RG7716 in diabetic macular edema: Key secondary and exploratory outcomes in the phase 2 BOULEVARD clinical trial
D. Eichenbaum United States
15:00Choroid of diabetic patients without observed retinal vascular changes: A longitudinal study
J. Cardigos Portugal
15:06Characterization of the initial stages of diabetic retinal disease using OCT and OCTA
I. Marques Portugal
15:12Prolonged oxygen support and retinopathy of prematurity (ROP) recurrence post intravitreal anti vascular endothelial growth factor (VEGF) injection in zone 1
H. Al Hasid United Arab Emirates
15:18Does the duration of chronic diabetic oedema influence the effectiveness and safety outcomes achieved in patients treated with ILUVIEN (fluocinolone acetonide)? Clinical insights from the ILUVIEN registry safety study
U. Chakravarthy United Kingdom
15:24Parafoveal capillary density changes in the early stages of diabetic retinopathy evaluated with OCTangiography
T. Rodrigues Portugal
15:30Choroidal predictors for visual response to antiVEGF treatment in DME patients, using swept source OCT
A. Santos Portugal
15:36Changes in aqueous cytokine levels following treatment with aflibercept in treatment naïve patients with diabetic macular edema
R. Muni Canada
15:42Intravitreal triamcinolone injections in nonarteritic anterior ischemic optic neuropathy – 7 years followup
E. Durbant France
15:48Fenofibrate treatment in diabetic retinopathy with dyslipidemia: Effects on central macular thickness and macular volume, and serum endothelial nitric synthase, vascular cell adhesion molecule 1, and vascular endothelial growth factor levels
G. Adriono Indonesia
15:54A national audit of UK electronic medical records (EMRs) to assess the safety and effectiveness of the ILUVIEN (fluocinolone acetonide) 190 micrograms intravitreal implant in patients with chronic diabetic macular oedema (DMO)
C. Bailey United Kingdom
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait